Dalian BIO-CHEM Company Limited
603360.SS · SHH
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Growth | 2.3% | -33% | 7.8% | – |
| Cost of Goods Sold | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Gross Profit | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 34.7% | 34.9% | 31.5% | 38.5% |
| R&D Expenses | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| G&A Expenses | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| SG&A Expenses | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Sales & Mktg Exp. | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Other Operating Expenses | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Operating Expenses | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Operating Income | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 14.7% | 15% | 15.6% | 30.7% |
| Other Income/Exp. Net | -CN¥0 | CN¥0 | -CN¥0 | -CN¥0 |
| Pre-Tax Income | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Tax Expense | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Net Income | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 10.8% | 13.9% | 11.2% | 21.9% |
| EPS | 0.047 | 0.083 | 0.1 | 0.18 |
| % Growth | -42.9% | -17% | -44.4% | – |
| EPS Diluted | 0.047 | 0.083 | 0.1 | 0.18 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Interest Expense | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Depreciation & Amortization | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| EBITDA | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 15.1% | 23.9% | 20.1% | 33.2% |